Cargando…
Serum cytokine levels and other associated factors as possible immunotherapeutic targets and prognostic indicators for lung cancer
Lung cancer is one of the most prevalent cancer types and the leading cause of cancer-related deaths worldwide. Non-small cell lung cancer (NSCLC) accounts for 80-85% of all cancer incidences. Lung cancer therapy and prognosis largely depend on the disease’s degree at the diagnosis time. Cytokines a...
Autores principales: | Zhao, Yinghao, Jia, Shengnan, Zhang, Kun, Zhang, Lian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9977806/ https://www.ncbi.nlm.nih.gov/pubmed/36874133 http://dx.doi.org/10.3389/fonc.2023.1064616 |
Ejemplares similares
-
Exploration of the Prognostic and Immunotherapeutic Value of B and T Lymphocyte Attenuator in Skin Cutaneous Melanoma
por: Dong, Xubin, et al.
Publicado: (2021) -
Beyond CAR T Cells: Other Cell-Based Immunotherapeutic Strategies Against Cancer
por: Patel, Shabnum, et al.
Publicado: (2019) -
Prognostic Biomarkers and Immunotherapeutic Targets Among CXC Chemokines in Pancreatic Adenocarcinoma
por: Huang, Jiacheng, et al.
Publicado: (2021) -
Identification and validation of a novel phagocytosis regulators-related signature with potential prognostic and immunotherapeutic value in patients with lung adenocarcinoma
por: Li, Jingyang, et al.
Publicado: (2022) -
Immunotherapeutic Advancements for Glioblastoma
por: Ampie, Leonel, et al.
Publicado: (2015)